FDA Inspection
RMA Long Island IVFRMA Long Island IVF – FDA Inspection, Oct 20, 2010
Record Details
This FDA Inspection record concerns RMA Long Island IVF, with an inspection on October 20, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- RMA Long Island IVF
- Inspection Date
- October 20, 2010
- Product Type
- Biologics
View Company Profile
ID · aa83acbb-5e94-46e9-bea8-24fa6ce85e90
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 695053
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.55(d)(2)Accurate, indelible, legible
- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RMA Long Island IVF
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 1, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 13, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 16, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for RMA Long Island IVF
- FDA Inspection 1229041 - 2024-02-09
- FDA Inspection 1163524 - 2022-03-01
- FDA Inspection 1076523 - 2018-12-13
- FDA Inspection 994705 - 2016-12-20
- FDA Inspection 900033 - 2014-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.